HIV & AIDS

HIV antibodies protect animals in proof-of-concept study

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people. The ...

Diseases, Conditions, Syndromes

Study uncovers new biological marker for scleroderma

A cross-disciplinary University of Alberta research team has uncovered a biological marker for scleroderma that can predict which patients will develop severe disease and could also lead to new treatments.

page 6 from 40